Australia markets closed
  • ALL ORDS

    7,649.30
    -32.00 (-0.42%)
     
  • ASX 200

    7,342.60
    -27.60 (-0.37%)
     
  • AUD/USD

    0.7264
    -0.0035 (-0.48%)
     
  • OIL

    73.95
    +0.65 (+0.89%)
     
  • GOLD

    1,748.20
    -1.60 (-0.09%)
     
  • BTC-AUD

    58,641.92
    -3,150.66 (-5.10%)
     
  • CMC Crypto 200

    1,060.57
    -42.49 (-3.85%)
     
  • AUD/EUR

    0.6195
    -0.0016 (-0.25%)
     
  • AUD/NZD

    1.0352
    +0.0038 (+0.37%)
     
  • NZX 50

    13,259.55
    -46.37 (-0.35%)
     
  • NASDAQ

    15,329.68
    +13.10 (+0.09%)
     
  • FTSE

    7,051.48
    -26.87 (-0.38%)
     
  • Dow Jones

    34,798.00
    +33.18 (+0.10%)
     
  • DAX

    15,531.75
    -112.22 (-0.72%)
     
  • Hang Seng

    24,192.16
    -318.82 (-1.30%)
     
  • NIKKEI 225

    30,248.81
    +609.41 (+2.06%)
     

Jory Bell (Playground Global) + Jen Nwankwo (1910 Genetics)

After the last year+, VC money has been pouring into biotech companies, and 1910 Genetics is no different. Hear from founder and CEO Jen Nwankwo and investor Jory Bell, from Playground Global, about how to fundraise in the bio/health tech sector and use that financing to your advantage.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting